eRoomSystem (ERMS) 10-Q 14 Nov 16 2016 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 14, 2016
Document Information [Line Items]
Entity Registrant Name	eRoomSystem Technologies Inc
Entity Central Index Key	1,110,361
Trading Symbol	erms
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		24,217,865
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 1,638,990	$ 1,247,739
Investment in available for sale securities	24,886	23,640
Notes receivable	573,324	1,075,020
Accounts receivable, net of allowance for doubtful accounts of $7,005 and $5,044	93,070	67,008
Inventory	101,244	101,928
Advance to hotels	80,998	78,473
Prepaid expenses	23,479	3,369
Total Current Assets	2,535,991	2,597,177
PROPERTY AND EQUIPMENT
Property and equipment, net of accumulated depreciation of $31,287 and $23,524	31,482	39,810
INVESTMENT IN REAL PROPERTY TAX LIENS	3,143	3,143
DEPOSITS AND OTHER ASSETS	2,933	2,933
Total Assets	2,573,549	2,643,063
CURRENT LIABILITIES
Accounts payable	25,760	12,485
Accrued liabilities	24,303	80,195
Total Current Liabilities	50,063	92,680
Total Liabilities	50,063	92,680
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none outstanding
Common stock, $0.001 par value; 50,000,000 shares authorized; shares outstanding 24,217,865 and 24,217,865	24,218	24,218
Additional paid-in capital	34,218,040	34,211,957
Accumulated deficit	(31,720,924)	(31,686,698)
Accumulated other comprehensive income	2,152	906
Total Stockholders' Equity	2,523,486	2,550,383
Total Liabilities and Stockholders' Equity	$ 2,573,549	$ 2,643,063

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Allowance for doubtful accounts	$ 7,044	$ 5,044
Accumulated depreciation	$ 31,287	$ 23,524
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares outstanding (in shares)	24,217,865	24,217,865

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
REVENUE	$ 214,413	$ 229,873	$ 677,834	$ 644,163
COST OF REVENUE	137,022	137,596	422,144	371,963
GROSS MARGIN	77,391	92,277	255,690	272,200
OPERATING EXPENSES
Selling, general and administrative expense, including non-cash compensation of $0, $1,619, $6,084 and $8,054	110,331	95,114	302,736	290,382
Research and development expense	15,550	13,103	39,657	35,672
Net Operating Expenses	125,881	108,217	342,393	326,054
OTHER INCOME
Investment Income	10,520	23,464	52,477	104,407
Net Income (Loss)	(37,970)	7,524	(34,226)	50,553
Other Comprehensive Income (Loss)
Unrealized holding gain (loss)	(286)	(801)	1,246	(437)
Comprehensive Income (Loss)	$ (38,256)	$ 6,723	$ (32,980)	$ 50,116
Basic Income (Loss) Per Common Share (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Diluted Income (Loss) Per Common Share (in dollars per share)	$ 0	$ 0	$ 0	$ 0

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Selling, general and administrative expense, non-cash compensation	$ 0	$ 1,619	$ 6,084	$ 8,054

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (34,226)	$ 50,553
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	7,764	8,441
Accrued interest receivable	5,494	(2,539)
Gain on sale of marketable securities		(40,160)
Selling, general and administrative expense, non-cash compensation	6,084	8,054
Changes in operating assets and liabilities:
Restricted cash		61,350
Accounts receivable	(26,062)	(35,927)
Inventory	20,370	(17,624)
Advance to hotels	(2,525)	(1,973)
Prepaid expenses	(20,110)	417
Accounts payable	7,775	4,613
Accrued liabilities	(50,392)	(33,604)
Borrowed shares		(60,959)
Net Cash Used In Operating Activities	(85,829)	(59,358)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(19,122)
Purchases of investments in real property tax liens		(3,698)
Advances made under notes receivable	(150,000)	(390,000)
Proceeds from collection of note receivable	646,202	270,624
Purchase of marketable securities		(618,107)
Proceeds from sale of marketable securities		758,267
Net Cash Provided by Investing Activities	477,080	17,086
Net Increase (Decrease) in Cash	391,251	(42,272)
Cash and cash equivalents at Beginning of Period	1,247,739	1,453,971
Cash and cash equivalents at End of Period	$ 1,638,990	$ 1,411,699

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Condensed Financial Statements Cash and Cash Equivalents Investments in Debt and Equity Securities Available for Sale Accounts Receivable Inventory - Advances to Hotels Notes Receivable Investment in Real Property Tax Liens – Property and Equipment: Net Earnings (Loss) per Common Share The following table is a reconciliation of the numerators and denominators used in the calculation of basic and diluted loss per share for the three and nine months ended September 30, 2016 and 2015: For the three months ended September 30, For the nine months ended September 30, 2016 2015 2016 2015 Net income (loss) $ (37,970 ) $ 7,524 $ (34,226 ) $ 50,553 Basic weighted-average common shares outstanding 24,217,865 24,176,107 24,217,865 24,172,009 Effect of dilutive securities Stock options and warrants - 44,236 - 39,306 Diluted weighted-average common shares outstanding 24,217,865 24,220,343 24,217,865 24,211,315 Basic income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Diluted income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 During the nine months ended September 30, 2015, there were 92,500 of potential common stock equivalents from options that were not included in the computation of diluted loss per share because their effect would have been anti-dilutive. During the nine months ended September 30, 2016, there were 400,000 of potential common stock equivalents from options that were not included in the computation of diluted loss per share because their effect would have been anti-dilutive.

Note 2 - Investments

Note 2 - Investments	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Cost and Equity Method Investments Disclosure [Text Block]	NOTE 2 – INVESTMENTS Investment in Real Property Tax Liens Investment in Available for Sale Debt Securities Debt and Equity Securities Cost Basis Unrealized Gains Unrealized Losses Fair Value Corporate Debt Securities $ 22,734 $ 2,152 $ - $ 24,886 Total $ 22,734 $ 2,152 $ - $ 24,886 The corporate debt securities mature on August 31, 2018 and May 29, 2020.

Note 3 - Notes Receivable

Note 3 - Notes Receivable	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 3 – NOTES RECEIVABLE To date, the Company loaned $1,642,000 in amounts ranging from $150,000 to $450,000 to various parties for a one year term with mortgage notes ranging in interest from 4.5% - 12%. Interest is due and payable monthly. The entire principal amounts are due and payable on the maturity date. The mortgages are collateralized by either commercial or residential property. Proceeds collected on these notes during the nine months ended September 30, 2016 totaled $646,202 and during the year ended December 31, 2015 totaled $272,512. The carrying amounts of loans outstanding on September 30, 2016 and December 31, 2015 were $573,324 and $1,075,020 including interest accrued. The carrying amount of the notes receivable approximates their fair values based on their short-term maturity. Accrued interest on notes receivable was $2,037 and $7,531 at September 30, 2016 and December 31, 2015 respectively, and was included in notes receivable in the accompanying consolidated balance sheets.

Note 4 - Stockholders' Equity

Note 4 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 4 – STOCKHOLDERS’ EQUITY During the nine months ended September 30, 2016, the Company granted options to purchase 75,000 shares of common stock to employees for services rendered. These options, which vested immediately, have an exercise price of $0.06 per share and are exercisable through March 31, 2021. These options were valued at approximately $0.05 per share, or $3,650, using the Black-Scholes option pricing model with the following assumptions: market value of the common stock of $0.06 per share, risk free interest rate of 1.21%, dividend yield of 0.0%, volatility of 116% and expected life of 5 years. The pricing model utilized the full life of the options as the Company generally has a low turnover rate of its employees. During the nine months ended September 30, 2016, the Company granted options to purchase 50,000 shares of common stock to a consultant for services rendered. These options, which vested immediately, have an exercise price of $0.06 per share and are exercisable through April 1, 2021. These options were valued at approximately $0.05 per share, or $2,434, using the Black-Scholes option pricing model with the following assumptions: market value of the common stock of $0.06 per share, risk free interest rate of 1.21%, dividend yield of 0.0%, volatility of 116% and expected life of 5 years. Stock-based compensation expense relating to stock options of $6,084 and $8,054 was recognized during the nine months ended September 30, 2016 and 2015, respectively. There was no unrecognized compensation related to stock options at September 30, 2016. A summary of stock option and warrant activity for the nine months ended September 30, 2016 is as follows: Options and Warrants Exercise Price Range Weighted - Average Exercise Price Weighted- Average Life Aggregate Intrinsic Value Balance, December 31, 2015 300,000 $0.05 - $0.17 $ 0.08 5.40 $ - Granted 125,000 0.06 - 0.06 0.06 Expired (25,000 ) 0.17 - 0.17 0.17 Balance, September 30, 2016 400,000 0.05 - 0.12 0.06 5.00 $ 750 Exercisable, September 30, 2016 400,000 $0.05 - $0.12 $ 0.06 5.00 $ 750 Weighted-average fair value of options granted during the nine months ended September 30, 2016 $ 0.05 All of the options and warrants were exercisable at September 30, 2016. At September 30, 2016 the intrinsic value for the options and warrants outstanding was $750.

Note 5 - Fair Value of Financia

Note 5 - Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 5 – FAIR VALUE OF FINANCIAL INSTRUMENTS Generally accepted accounting principles define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. To measure fair value, a hierarchy has been established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. This hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3 – Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The Company uses fair value to measure certain assets and liabilities on a recurring basis when fair value is the primary measure for accounting. Fair value is also used on a nonrecurring basis to measure certain assets when applying lower of cost or market accounting or when adjusting carrying values. Fair value is also used when evaluating impairment on certain assets, including notes receivable and long-lived assets. The following table sets forth the estimated fair values of the Company’s financial instruments that are measured at fair value on a reoccurring basis as of September 30, 2016 and December 31, 2015: Fair Value of Financial Instruments Quoted Prices in Active Markets Significant for Identical Significant Unobservable Assets Observable Inputs Inputs Total (Level 1) (Level 2) (Level 3) September 30, 2016 Assets: Debt securities available for sale $ 24,886 $ - $ 24,886 $ - December 31, 2015 Assets: Debt securities available for sale $ 23,640 $ - $ 23,640 $ - Fair Value of Financial Instruments Not Required To Be Reported at Fair Value The fair values of real property tax liens and notes receivable are based on a combination of the stated or implied interest rates at the measurement dates, approximate their carrying amounts and are considered to fall within Level 3 of the fair value hierarchy.

Note 6 - Concentration of Credi

Note 6 - Concentration of Credit Risk and Significant Customers	9 Months Ended
	Sep. 30, 2016
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE 6 – CONCENTRATION OF CREDIT RISK AND SIGNIFICANT CUSTOMERS The Company's historical revenues and receivables have been derived primarily from the lodging industry. The Company offers credit terms in connection with its sale of products from refreshment centers. The Company performs ongoing credit evaluations of its customers' financial condition and does not require collateral from its customers. The Company maintains an allowance for uncollectible accounts receivable based upon a percentage of accounts receivable at year end. At September 30, 2016, the Company had accounts receivable from one customers which accounted for 38% of total accounts receivable and from a second customer which accounted for 21% of total accounts receivable. During the nine months ended September 30, 2016, revenues from one customer accounted for 37% of total revenues and 26% from a second customer. During the nine months ended September 30, 2015, revenues from one customer accounted for 34% of total revenues and 28% from a second customer.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Condensed Financial Statements
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
Marketable Securities, Policy [Policy Text Block]	Investments in Debt and Equity Securities Available for Sale
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable
Inventory, Policy [Policy Text Block]	Inventory -
Receivables, Policy [Policy Text Block]	Advances to Hotels
Finance, Loans and Leases Receivable, Policy [Policy Text Block]	Notes Receivable
Investment, Policy [Policy Text Block]	Investment in Real Property Tax Liens –
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment:
Earnings Per Share, Policy [Policy Text Block]	Net Earnings (Loss) per Common Share The following table is a reconciliation of the numerators and denominators used in the calculation of basic and diluted loss per share for the three and nine months ended September 30, 2016 and 2015: For the three months ended September 30, For the nine months ended September 30, 2016 2015 2016 2015 Net income (loss) $ (37,970 ) $ 7,524 $ (34,226 ) $ 50,553 Basic weighted-average common shares outstanding 24,217,865 24,176,107 24,217,865 24,172,009 Effect of dilutive securities Stock options and warrants - 44,236 - 39,306 Diluted weighted-average common shares outstanding 24,217,865 24,220,343 24,217,865 24,211,315 Basic income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Diluted income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 During the nine months ended September 30, 2015, there were 92,500 of potential common stock equivalents from options that were not included in the computation of diluted loss per share because their effect would have been anti-dilutive. During the nine months ended September 30, 2016, there were 400,000 of potential common stock equivalents from options that were not included in the computation of diluted loss per share because their effect would have been anti-dilutive.

Note 1 - Basis of Presentatio14

Note 1 - Basis of Presentation and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the three months ended September 30, For the nine months ended September 30, 2016 2015 2016 2015 Net income (loss) $ (37,970 ) $ 7,524 $ (34,226 ) $ 50,553 Basic weighted-average common shares outstanding 24,217,865 24,176,107 24,217,865 24,172,009 Effect of dilutive securities Stock options and warrants - 44,236 - 39,306 Diluted weighted-average common shares outstanding 24,217,865 24,220,343 24,217,865 24,211,315 Basic income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Diluted income (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00

Note 2 - Investments (Tables)

Note 2 - Investments (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	Debt and Equity Securities Cost Basis Unrealized Gains Unrealized Losses Fair Value Corporate Debt Securities $ 22,734 $ 2,152 $ - $ 24,886 Total $ 22,734 $ 2,152 $ - $ 24,886

Note 4 - Stockholders' Equity (

Note 4 - Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Share-based Compensation, Activity [Table Text Block]	Options and Warrants Exercise Price Range Weighted - Average Exercise Price Weighted- Average Life Aggregate Intrinsic Value Balance, December 31, 2015 300,000 $0.05 - $0.17 $ 0.08 5.40 $ - Granted 125,000 0.06 - 0.06 0.06 Expired (25,000 ) 0.17 - 0.17 0.17 Balance, September 30, 2016 400,000 0.05 - 0.12 0.06 5.00 $ 750 Exercisable, September 30, 2016 400,000 $0.05 - $0.12 $ 0.06 5.00 $ 750 Weighted-average fair value of options granted during the nine months ended September 30, 2016 $ 0.05

Note 5 - Fair Value of Financ17

Note 5 - Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Quoted Prices in Active Markets Significant for Identical Significant Unobservable Assets Observable Inputs Inputs Total (Level 1) (Level 2) (Level 3) September 30, 2016 Assets: Debt securities available for sale $ 24,886 $ - $ 24,886 $ - December 31, 2015 Assets: Debt securities available for sale $ 23,640 $ - $ 23,640 $ -

Note 1 - Basis of Presentatio18

Note 1 - Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Other than Temporary Impairment Losses, Investments	$ 0		$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	400,000	92,500

Note 1 - Basis of Presentatio19

Note 1 - Basis of Presentation and Significant Accounting Policies - Schedule of Earnings Per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net income (loss)	$ (37,970)	$ 7,524	$ (34,226)	$ 50,553
Basic weighted-average common shares outstanding (in shares)	24,217,865	24,176,107	24,217,865	24,172,009
Effect of dilutive securities
Stock options and warrants (in shares)		44,236		39,306
Diluted weighted-average common shares outstanding (in shares)	24,217,865	24,220,343	24,217,865	24,211,315
Basic Income (Loss) Per Common Share (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Diluted Income (Loss) Per Common Share (in dollars per share)	$ 0	$ 0	$ 0	$ 0

Note 2 - Investments (Details T

Note 2 - Investments (Details Textual)	9 Months Ended
	Sep. 30, 2016USD ($)
Collateralized Mortgage Obligations [Member]
Investment Owned, at Fair Value	$ 3,143
Minimum [Member]
Investment in real property tax liens, penalty rate	2.00%
Maximum [Member]
Investment in real property tax liens, penalty rate	6.00%
Investment Interest Rate	18.00%

Note 2 - Investments - Schedule

Note 2 - Investments - Schedule of Available-for-sale Equity Securities Reconciliation (Details) - USD ($)	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Debt Securities [Member]
Cost Basis	$ 22,734
Unrealized Gains	2,152
Unrealized Losses	0
Fair Value	24,886
Cost Basis	22,734
Unrealized Gains	2,152
Unrealized Losses	0
Fair Value	$ 24,886	$ 23,640

Note 3 - Notes Receivable (Deta

Note 3 - Notes Receivable (Details Textual) - USD ($)	9 Months Ended		12 Months Ended	33 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Sep. 30, 2016
Notes Receivable [Member] | Minimum [Member]
Payments to Acquire Notes Receivable, Range				$ 150,000
Loan Receivable, Interest Rate				4.50%
Notes Receivable [Member] | Maximum [Member]
Payments to Acquire Notes Receivable, Range				$ 450,000
Loan Receivable, Interest Rate				12.00%
Notes Receivable [Member]
Payments to Acquire Notes Receivable, Range				$ 1,642,000
Loan Receivable Term (years)				1 year
Proceeds from Collection of Notes Receivable	$ 646,202		$ 272,512
Notes, Loans and Financing Receivable, Net, Current	573,324		1,075,020	$ 573,324
Interest Receivable, Current	2,037		$ 7,531	$ 2,037
Proceeds from Collection of Notes Receivable	$ 646,202	$ 270,624

Note 4 - Stockholders' Equity23

Note 4 - Stockholders' Equity (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Employee Stock Option [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 0
Allocated Share-based Compensation Expense	$ 6,084	$ 8,054
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	75,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$ 0.05
Stock Granted, Value, Share-based Compensation, Gross	$ 3,650
Share Price	$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.21%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	116.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	5 years
Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$ 0.05
Stock Granted, Value, Share-based Compensation, Gross	$ 2,434
Share Price	$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.21%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	116.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	5 years
Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Intrinsic Value	$ 750

Note 4 - Stockholders' Equity -

Note 4 - Stockholders' Equity - Schedule of Share-based Compensation, Activity (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Minimum [Member]
Options and Warrants, Exercise Price Range (in dollars per share)	$ 0.05
Options and Warrants, Granted, Exercise Price Range (in dollars per share)	0.06
Options and Warrants, Expired, Exercise Price Range (in dollars per share)	0.17
Options and Warrants, Exercise Price Range (in dollars per share)	0.05	$ 0.05
Exercisable, December 31, 2015, Exercise Price Range (in dollars per share)	0.05
Maximum [Member]
Options and Warrants, Exercise Price Range (in dollars per share)	0.17
Options and Warrants, Granted, Exercise Price Range (in dollars per share)	0.06
Options and Warrants, Expired, Exercise Price Range (in dollars per share)	0.17
Options and Warrants, Exercise Price Range (in dollars per share)	0.12	$ 0.17
Exercisable, December 31, 2015, Exercise Price Range (in dollars per share)	$ 0.12
Options and Warrants, Balance (in shares)	300,000
Options and Warrants, Weighted Average Exercise Price (in dollars per share)	$ 0.08
Options and Warrants, Weighted-Average Life	5 years	5 years 146 days
Options and Warrants, Granted (in shares)	125,000
Options and Warrants, Granted, Weighted Average Exercise Price (in dollars per share)	$ 0.06
Options and Warrants, Expired (in shares)	(25,000)
Options and Warrants, Expired, Weighted Average Exercise Price (in dollars per share)	$ 0.17
Options and Warrants, Balance (in shares)	400,000	300,000
Options and Warrants, Weighted Average Exercise Price (in dollars per share)	$ 0.06	$ 0.08
Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Intrinsic Value	$ 750
Exercisable, December 31, 2015, Options and Warrants (in shares)	400,000
Exercisable, December 31, 2015, weighted average exercise price (in dollars per share)	$ 0.06
Exercisable, December 31, 2015, weighted average life	5 years
Weighted-average fair value of options granted during the nine months ended September 30, 2016 (in dollars per share)	$ 0.05

Note 5 - Fair Value of Financ25

Note 5 - Fair Value of Financial Instruments - Schedule of Fair Value, Assets Measured On Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Inputs, Level 2 [Member]
Assets:
Debt securities available for sale	$ 24,886	$ 23,640
Debt securities available for sale	24,886	23,640
Debt securities available for sale	24,886	23,640
Debt securities available for sale	$ 24,886	$ 23,640

Note 6 - Concentration of Cre26

Note 6 - Concentration of Credit Risk and Significant Customers (Details Textual) - Customer Concentration Risk [Member]	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Customer A [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	38.00%
Customer A [Member] | Sales Revenue, Goods, Net [Member]
Concentration Risk, Percentage	37.00%	34.00%
Customer B [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage	21.00%
Customer B [Member] | Sales Revenue, Goods, Net [Member]
Concentration Risk, Percentage	26.00%	28.00%